MRK

Recent Articles

IPOs: 4 Stocks To Buy After The Plunge

IPOs have plunged mightily in recent weeks, but that doesn't mean you should avoid the sector entirely. Here are 4 IPO stocks to buy after the plunge. More 

Grass Pollen Allergy? New Grastek Pill From Merck Hits Shelves Soon

Merck says the U.S. Food and Drug Administration has approve the release of its Grastek grass pollen allergy drug, which will launch later this month. More 

Hottest Healthcare Stocks Now – WMGI PDLI GB MRK

Healthcare stocks declined broadly on Wall Street on Thursday morning, with the sector seeing an overall decline of 0.2%. NASDAQ:WMGI, NASDAQ:PDLI, NYSE:GB, NYSE:MRK, NASDAQ:SHPG, NASDAQ:ISRG, NYSE:WX, NYSE:TEVA, NASDAQ:ARTC, NYSE:CVD, NASDAQ:CLVS, NASDAQ:ALNY, NASDAQ:NKTR, NASDAQ:ALXN, NASDAQ:SGMO, NASDAQ:ISIS, NASDAQ:NBIX, NASDAQ:BMRN, NASDAQ:IMGN, NASDAQ:NPSP More 

5 Biotech Stocks Promising Future Rewards

Biotech is one of the dynamic sectors in our economy, and in the stock market as well. These 5 biotech stocks are solid buys in our Portfolio Grader model. More 

5 Pharmaceutical Stocks to Buy Now

The grades of five pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More 

8 Pharmaceutical Stocks to Buy Now

The grades of eight pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More 

5 Not-So-Crazy Blue-Chip Spinoffs

Here are some not-so-crazy spinoff ideas we might see in 2014 as some big-name blue chips look to streamline operations and align strategy with structure. More